Kelly McKee
Chief Tech/Sci/R&D Officer chez GEOVAX LABS, INC.
Fortune : 4 772 $ au 31/03/2024
Profil
Kelly T.
McKee is currently the Chief Medical Officer at GeoVax Labs, Inc. Previously, Kelly held positions such as Operations Director at Quintiles Transnational Corp., Senior Director-Clinical Research at DynPort Vaccine Co. LLC, Vice President-Vaccines & Public Health at IQVIA, Inc., Chief Medical Officer at Pharm-Olam International Ltd., and Chief Medical Officer at Bravovax Co., Ltd.
Kelly received an undergraduate degree from Davidson College, a graduate degree from The Johns Hopkins University, and a doctorate degree from The University of Virginia School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GEOVAX LABS, INC.
0,11% | 11/03/2024 | 2 386 ( 0,11% ) | 4 772 $ | 31/03/2024 |
Postes actifs de Kelly McKee
| Sociétés | Poste | Début |
|---|---|---|
| GEOVAX LABS, INC. | Chief Tech/Sci/R&D Officer | 06/01/2022 |
Anciens postes connus de Kelly McKee
| Sociétés | Poste | Fin |
|---|---|---|
| IMS HEALTH, INC. | Corporate Officer/Principal | - |
| Bravovax Co., Ltd. | Chief Tech/Sci/R&D Officer | - |
DynPort Vaccine Co. LLC
 DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services DynPort Vaccine Co. LLC develops vaccines, biologic products and small molecule anti-infectives. It provides its products and services to the defense and military sectors in the United States. The company was founded in 1997 by Zsolt Pál Harsányi and is headquartered in Reston, VA. | Corporate Officer/Principal | - |
Pharm-Olam International Ltd.
 Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | Chief Tech/Sci/R&D Officer | - |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Chief Operating Officer | - |
Formation de Kelly McKee
| Davidson College | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| The University of Virginia School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Quintiles Transnational Corp.
Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Commercial Services |
IQVIA, Inc.
 IQVIA, Inc. Data Processing ServicesTechnology Services IQVIA, Inc. provides information technology solutions to the healthcare industry. It offers research and development, enterprise information management, commercial analytics, market analysis, patient consent system, content management, and other related solutions. The company was founded by Bill Frohlich and David Dubow in 1954 and is headquartered in Danbury, CT. | Technology Services |
DynPort Vaccine Co. LLC
DynPort Vaccine Co. LLC Miscellaneous Commercial ServicesCommercial Services DynPort Vaccine Co. LLC develops vaccines, biologic products and small molecule anti-infectives. It provides its products and services to the defense and military sectors in the United States. The company was founded in 1997 by Zsolt Pál Harsányi and is headquartered in Reston, VA. | Commercial Services |
| GeoVax Labs, Inc. | |
Pharm-Olam International Ltd.
Pharm-Olam International Ltd. Miscellaneous Commercial ServicesCommercial Services Pharm-Olam International started operations in 1994 with the premise of delivering cost effective, quick-to-market clinical services in the emerging markets of Central and Eastern Europe. Since then, POI has expanded its services to more than 40 countries, including: North America, Western Europe, Central & Eastern Europe, Latin America, India, and South Africa. Today, POI has one of the largest global footprints of any CRO. They are committed to establishing and maintaining the industry's strongest multi-national presence. Its monitors have the most extensive knowledge of local and regional customs and sites across a broad range of therapeutic areas. POI has an entirely different model than other CROs- they call it global decentralization. The success of this model has been proven time and again. | Commercial Services |
| Bravovax Co., Ltd. |
